Literature DB >> 18958544

Atrophic gastritis, but not antibody to Helicobacter pylori, is associated with body mass index in a Japanese population.

Takehiro Torisu1, Takayuki Matsumoto, Yutaka Takata, Toshihiro Ansai, Inho Soh, Shuji Awano, Ikuo Nakamichi, Shuntaro Kagiyama, Kazuo Sonoki, Akihiro Yoshida, Tomoko Hamasaki, Mitsuo Iida, Tadamichi Takehara.   

Abstract

BACKGROUND: The relationship between Helicobacter pylori (HP) infection and body mass index (BMI) is controversial. Several reports have indicated that eradication of HP infection induces an increase in BMI. In contrast, epidemiological case-control studies have failed to show an association between HP infection and BMI. Therefore, we investigated whether HP and atrophic gastritis (AG) were associated with BMI.
METHODS: A total of 617 individuals were recruited for the measurements of BMI, serum leptin, pepsinogens (PGs) I and II, and IgG antibody to HP (HP-IgG). BMI and leptin of the subjects were compared when the subjects were stratified by HP-IgG and PGs.
RESULTS: The subjects were divided into AG-positive and AG-negative groups according to PGs (AG-positive: PG I < or = 70 ng/ml and PG I/II ratio < or =3.0). BMI after adjusting for sex and age was significantly lower in the AG-positive group than in the AG-negative group (23.47 +/- 3.05 vs. 24.18 +/- 3.25, P = 0.010). When the subjects were divided into two groups according to HP-IgG, BMI tended to be lower in the HP-IgG-positive group, though the difference was not large. When the subjects were divided into four groups for different combinations of AG and HP-IgG, BMI was the lowest in the AG-positive and HP-IgG-negative group.
CONCLUSIONS: BMI was associated with AG, as diagnosed by PGs, but not with HP infection status. These results mean that HP infection affects BMI via atrophic gastritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958544     DOI: 10.1007/s00535-008-2219-0

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  25 in total

1.  Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori.

Authors:  Yoshio Yamaoka; Julianne Souchek; Stefan Odenbreit; Rainer Haas; Anna Arnqvist; Thomas Borén; Tadashi Kodama; Michael S Osato; Oscar Gutierrez; Jong G Kim; David Y Graham
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Helicobacter pylori infection and atrophic gastritis in the elderly.

Authors:  M A Faisal; R M Russell; I M Samloff; P R Holt
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

3.  Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.

Authors:  Y Yamaoka; T Kodama; O Gutierrez; J G Kim; K Kashima; D Y Graham
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

4.  Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis.

Authors:  W E Karnes; I M Samloff; M Siurala; M Kekki; P Sipponen; S W Kim; J H Walsh
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

5.  Gastric leptin and Helicobacter pylori infection.

Authors:  T Azuma; H Suto; Y Ito; M Ohtani; M Dojo; M Kuriyama; T Kato
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

6.  Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Usama A Arafa; Toshiyuki Uchida; Kazunari Tominaga; Toshio Watanabe; Tetsuo Arakawa
Journal:  Hepatogastroenterology       Date:  2002 Sep-Oct

7.  Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.

Authors:  Yoshihisa Urita; Kazuo Hike; Naotaka Torii; Yoshinori Kikuchi; Eiko Kanda; Masahiko Sasajima; Kazumasa Miki
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.

Authors:  T Kamada; K Haruma; J Hata; H Kusunoki; A Sasaki; M Ito; S Tanaka; M Yoshihara
Journal:  Aliment Pharmacol Ther       Date:  2003-07-15       Impact factor: 8.171

9.  Serum pepsinogen in screening for gastric cancer.

Authors:  A Kodoi; M Yoshihara; K Sumii; K Haruma; G Kajiyama
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

10.  The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group.

Authors:  P M Webb; K J Hengels; H Møller; D G Newell; D Palli; J B Elder; M P Coleman; G De Backer; D Forman
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

View more
  11 in total

1.  Lower serum level of adiponectin is associated with increased risk of endoscopic erosive gastritis.

Authors:  Shunsuke Yamamoto; Kenji Watabe; Shusaku Tsutsui; Shinichi Kiso; Toshimitsu Hamasaki; Motohiko Kato; Yoshihiro Kamada; Yuichi Yoshida; Shinji Kihara; Miyuki Umeda; Aiko Furubayashi; Kazuo Kinoshita; Osamu Kishida; Takashi Fujimoto; Akira Yamada; Yoshifumi Tsukamoto; Norio Hayashi; Yuji Matsuzawa
Journal:  Dig Dis Sci       Date:  2011-03-30       Impact factor: 3.199

Review 2.  Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery.

Authors:  Marilia Carabotti; Chiara D'Ercole; Angelo Iossa; Enrico Corazziari; Gianfranco Silecchia; Carola Severi
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

3.  Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection.

Authors:  Hee Jin Kim; Nayoung Kim; Hyun Young Kim; Hye Seung Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Kyoung-Ho Lee; Young-Hoon Kim; Hee Man Kim; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2014-09-21       Impact factor: 7.370

4.  Risk factors for atrophic gastritis in the Japanese young and middle-aged: a study using double-contrast upper gastrointestinal barium X-ray radiography.

Authors:  Kimihiko Endo; Hiroshi Nakada; Yoshihito Kadota; Youichi Mizutani; Norihiro Shinkawa; Koji Onoe; Naoki Yoshinaga; Minako Azuma; Toshinori Hirai
Journal:  Jpn J Radiol       Date:  2018-09-27       Impact factor: 2.374

Review 5.  Influence of metabolic syndrome on upper gastrointestinal disease.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Tetsuo Kimura; Koichi Okamoto; Hiroshi Miyamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-07-02

6.  Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome.

Authors:  Atsushi Takeoka; Jun Tayama; Hironori Yamasaki; Masakazu Kobayashi; Sayaka Ogawa; Tatsuo Saigo; Masaki Hayashida; Susumu Shirabe
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

7.  The Prevalence of Helicobacter pylori in Estonian Bariatric Surgery Patients.

Authors:  Natalja Šebunova; Jelena Štšepetova; Toomas Sillakivi; Reet Mändar
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

8.  Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.

Authors:  Hong Yu; Ying Liu; Shujing Jiang; Yunfeng Zhou; Zheng Guan; Siyuan Dong; Fong-Fong Chu; Chunbo Kang; Qiang Gao
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

9.  Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice.

Authors:  Kyoko Inagaki-Ohara; Shiki Okamoto; Kazuyo Takagi; Kumiko Saito; Seiya Arita; Lijun Tang; Tetsuji Hori; Hiroaki Kataoka; Satoshi Matsumoto; Yasuhiko Minokoshi
Journal:  Nutr Metab (Lond)       Date:  2016-02-02       Impact factor: 4.169

10.  Influence of obesity and bariatric surgery on gastric cancer.

Authors:  Anna Carolina Batista Dantas; Marco Aurelio Santo; Roberto de Cleva; Rubens Antônio Aissar Sallum; Ivan Cecconello
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.